The UK veterinary vaccines market, excluding Foot and Mouth disease vaccines, was valued at 506.46 million USD in 2023. From 2013 to 2016, the market saw significant growth, peaking in 2016, before experiencing a downward trend from 2017 onwards. The last five years have witnessed a consistent decline with a CAGR of -1.59%, with the past two years showing a year-on-year decrease of around 1.5%.

Future trends to watch include:

Potential market stabilization as newer vaccines are developed and implemented.
Increased focus on innovation and research to counteract the decline.
Regulatory changes and advancements in biotechnology that may impact market dynamics.